Analyst Upgrades

• Deutsche Bank upgraded EMC (EMC) to buy from hold after channel checks indicated storage demand remains solid. The firm sees potential upside in 2011 from the company's new products and upped its target for shares to $25 from $20.
• BB&T upgraded American Commercial (ACLI) to buy with a $50 target based on pricing leverage and cost reductions.
• Argus upgraded Abercrombie (ANF) to buy with a $52 target based on accelerating comps.
• PerkinElmer (PKI) was upgraded to equal weight from underweight at Barclays.
• Valeant (VRX) was upgraded to market perform from underperform at Wells Fargo with a $26 to $28 valuation range.
• Blackrock (BLK) was upgraded to buy from hold at Deutsche Bank.

Analyst Upgrades

• FBR Capital upgraded Legg Mason (LM) to market perform from underperform, citing stabilizing outflows and an improved liquidity position.
• Walmart (WMT) was upgraded to buy from hold by Citigroup on expectations the company will regain market share from aggressive price cuts.
• Piper Jaffray upgraded Kirkland's (KIRK) to overweight from neutral following the company's Q4 results.
• Greenbrier (GBX) was upgraded to buy from hold by KeyBanc as the company believes that railcar fundamentals have improved.
• Citigroup upgraded WM Morrison (MRWSY) to buy from sell.
• HSBC raised Millicom (MICC) to overweight from neutral.
• HealthSouth (HLS) was raised to outperform from market perform by Raymond James.

Analyst Upgrades

• Oppenheimer upgraded Home Depot (HD) to outperform from perform on expectations that comp sales growth in the home improvement retail sector will accelerate. The firm has a $37 price target for Home Depot shares. The firm also reiterates an outperform rating on Lowe's (LOW).
• UBS upgraded Mattel (MAT) to buy from neutral, citing solid demand in core brands, strong free cash flow and improved cost structure, among other reasons. The firm raised its target to $26 from $21.
• Thomas Weisel upgraded Dreamworks (DWA) to overweight from market weight, citing upcoming releases and increased international expectations. The firm raised its target to $47 from $40.
• TD AmeriTrade (AMTD) was upgraded to outperform from market perform at FBR Capital.
• Whole Foods (WFMI) was upgraded to overweight from neutral at JPMorgan.
• Whiting Petroleum (WLL) was upgraded to overweight from equal weight at Barclays.

If you had told me in 2003 that HealthSouth Corp. (NYSE: HLS) would become a shining beacon of good corporate governance, I would have laughed.

That was when former chairman and CEO Richard Scrushy was charged with securities fraud by the SEC. In 2005, he was convicted of money laundering, extortion, obstruction of justice, racketeering, and bribery. Now he's wasting away in Club Fed -- a far fall for a CEO who was so narcissistic that he insisted that his portrait be hung in the lobby of every one of the rehab facilities his company operated.

Analyst upgrades:

• Natixis expects Alcatel-Lucent's (NYSE: ALU) results to improve in 2H09, driven by the CDMA segment and completion of Lucent integration. Shares were upgraded to Buy from Reduce.
• RBC Capital upgraded Canadian Pacific (NYSE: CP) to Outperform from Sector Perform and raised its target to $67 from $49. The firm expects a return to "normalized" operating environment driven by Potash and MetCoal.
• Credit Suisse upgraded Affiliated Managers Group (NYSE: AMG) to Outperform from Neutral and raised its target to $69 from $64. The firm cites valuation, potential upside from 2H09 deals, and expectations for positive 2H09 flows for the upgrade.
• Kennametal (NYSE: KMT) coverage was assumed with a Neutral from Underweight at JPMorgan.
• Cardinal Financial (NASDAQ: CFNL) was upgraded to Outperform from Neutral at Baird.
• General Maritime (NYSE: GMR) was upgraded to Outperform from Market Perform at FBR Capital.

Analyst upgrades:

• Deutsche Bank upgraded HealthSouth (NYSE: HLS) and Rehabcare (NYSE: RHB) to Buy from Hold after raising its Post Acute Care sector view to Positive from Neutral. The firm believes volumes and margin leverage can drive better than expected Q2 results and 2009 guidance. The firm raised its target on HealthSouth shares to $16 from $12 and on Rehabcare to $28 from $19.
  
• Jefferies upgraded Moody's (NYSE: MCO) to Hold from Underperform to reflect stabilizing credit markets and its belief regulatory concerns are overstated. The firm raised its target on shares to $30 from $19.
  
• Keefe Bruyette upgraded Goldman Sachs (NYSE: GS) to Outperform from Market Perform as it finds the stock inexpensive following the better than expected results. The firm has a $195 target on shares.
• Vale (NASDAQ: VALE) was upgraded to Buy from Neutral at BofA/Merrill.
  
• CNOOC (NYSE: CEO) was upgraded to Overweight from Equal Weight at Morgan Stanley.
  
• International Game Tech (NYSE: IGT) was upgraded to Buy from Neutral at Janney Montgomery.
  

Analyst upgrades:

• Canaccord upgraded Rio Tinto (NYSE: RTP) to Buy from Hold citing valuation following the severe price decline following BHP Billiton's (NYSE: BHP) dropped bid.
• UBS upgraded Itron (NASDAQ: ITRI) to Buy from Neutral citing valuation and defensive business mix.
• Jefferies upgraded shares of HealthSouth (NYSE: HLS) to Buy from Hold on valuation and maintains a $13.50 target.
• Melco PBL Entertainment (NASDAQ: MPEL) was raised to buy from Neutral at Goldman.
• PG&E (NYSE: PCG) was upgraded at Merrill Lynch to Buy from Neutral.
• HSBC Holdings (NYSE: HBC) was upgraded to Buy from Neutral at UBS.

Analyst downgrades:

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Agilent Technologies Inc. (NYSE: A) topped estimates but offered an outlook below expectations.
• Best Buy Co. (NYSE: BBY) warned that it many not be able to maintain its earnings momentum.
• Charlotte Russe Holding Inc. (NASDAQ: CHIC) was upgraded because of its growth potential.
• Focus Media Holding Ltd. (NASDAQ: FMCN) shares tumbled after it reported Q3 numbers.
• HLS Systems International (NASDAQ: HOLI) earnings prospects and management impressed an analyst.
• JCPenney Co. Inc. (NYSE: JCP) reported a lower Q3 profit and lowered its guidance due to the recession.
• KKR Financial Holdings (NYSE: KFN) disappointing Q3 results led to analyst downgrades.
• MercadoLibre Inc. (NASDAQ: MELI) doubled its Q3 profit and beat earnings expectations.
• Nortel Networks Corp. (NYSE: NT) swung to a Q3 net loss and unveiled further restructuring measures.
• Perry Ellis International Inc. (NASDAQ: PERY) posted preliminary Q3 results and lowered its outlook.
• Siemens (NYSE: SI) Q4 net loss widened and it warned about meeting its profit target for the year.
• Starbucks Corp. (NASDAQ: SBUX) Q4 earnings were hurt by restructuring costs, revenue rose slightly.
• Toll Brothers Inc. (NYSE: TOL) posted dismal Q4 results and declined to offer guidance for next year.
• Tyson Foods Inc. (NYSE: TSN) solid Q4 results fell short of estimates and it offered a shaky outlook.
• Wells Fargo & Co. (NYSE: WFC) earnings prospects following its equity offering led to an analyst's upgrade.

Analyst upgrades:

• Jefferies upgraded shares of Safeway (NYSE: SWY) to Hold from Underperform on valuation as they believe the company's pricing pressure and sluggish sales trends are now priced in. The firm raised its target to $23.50 from $21.
  
• Merrill upgraded Pfizer (NYSE: PFE) to Buy from Underperform citing attractive dividend yield and stabilizing businesses.
  
• Banc of America upgraded shares of Apollo Group (NASDAQ: APOL) to Neutral from Sell and raised APOL's target to $60 from $48 on valuation as they see a balanced risk/reward at current levels.
• Nucor (NYSE: NUE) was raised to Overweight from Equal Weight at Morgan Stanley.
  
• Citrix Systems (NASDAQ: CTXS) and Symantec (NASDAQ: SYMC) were upgraded to Overweight from Neutral at JP Morgan.
  
• Keefe Bruyette upgraded Jefferies Group (NYSE: JEF) and Bank of America (NYSE: BAC) to Market Perform from Underperform.

Analyst downgrades:

MOST NOTEWORTHY: Stryker, General Dynamics and Garmin were today's noteworthy upgrades:

• Baird upgraded shares of Stryker (NYSE: SYK) to Outperform from Neutral as they believe the company's manufacturing problems are more manageable than expected and that supply constraints involving the Trident acetabular cup appear more limited.
  
• Wachovia raised General Dynamics (NYSE: GD) to Outperform from Market Perform, citing valuation, likely resumption in buybacks, and conservative guidance.
  
• Oppenheimer upgraded shares of Garmin (NASDAQ: GRMN) to Outperform from Perform on valuation, as they believe sentiment has troughed and that downward revisions are already priced into shares.

OTHER UPGRADES:

• Merrill raised Turkcell (NYSE: TKC) to Buy from Neutral.
  
• Lehman upgraded HealthSouth (NYSE: HLS) to Overweight from Underweight.
  
• Bear Stearns upgraded McAfee (NYSE: MFE) to Outperform from Peer Perform.

HealthSouth Corp. (NYSE: HLS) was one of those one-in-a-lifetime stocks. Once a highflier trading on the New York Stock Exchange, it descended to the Pink Sheets in the midst of a wave of accounting and management scandals. Federal agents raided the company's headquarters, and a stock that had traded in the 20's not so long ago sank below a dime.

Then just as quickly as it had collapsed, the stock bounced back. Some investors had turned $5 thousand investments into over a million as the company avoided bankruptcy and made a rebound.

In a world where major accounting scandals, SEC charges, and federal raids are a usually a sign of the end, HealthSouth's new management team led the company to an incredible recovery.

Dr. William Cast is a doctor who had worked for a clinic that was acquired by the company, and later became an investor who followed the stock through a Yahoo! Inc. (NASDAQ: YHOO) message board. Going South: An Inside Look at Corruption and Greed, and the Power of the HealthSouth Message Board is the product of that experience. While the financial media was declaring the stock good as dead, Yahoo! posters analyzed the company's prospects and decided it would be able to pull through. Cast and others backed up the truck and became some of the very, very few investors to achieve an early retirement by investing in a Pink Sheets stock under FBI investigation.

Health South is an exception of course, and scandal-ridden companies should probably be avoided like the plague by most investors. But this book is a pretty exciting tale of the power the internet can, but rarely does, have in allowing investors to share due diligence.

While investors around the world have been dumping stocks the past few days, HealthSouth Corporation (NYSE: HLS), the restructured rehabilitation company, reported one heck of a quarter.

The company now expects to generate 2007 EBITDA of $300 and analysts are forecasting 2008 EBITDA of $360 million. Interest expense is estimated to come in at $200 million, maintenance capex of $30 million, leaving $120 million to $130 million for debt reduction and fund growth.

More importantly in today's tight credit market, the company was able to lock in all of its debt expense on low-cost, fixed-rate terms -- before the recently brutal change in the credit markets.

New HealthSouth management joined the company in 2004 and the fruits of their labor are just paying off. This is one gem of a turnaround investors should bottom fish on during this market correction.

Leerink Swann & Company, an investment banking firm specializing in the healthcare sector, reiterated its $27 price target on this $17 stock this morning.

Broader credit market worries sacked stock futures Thursday after French banking group BNP Paribas suspended three funds -- tying up client investments -- saying it could not accurately value them due to a lack of liquidity throughout the U.S. securities market. The news sent U.S. bank stocks lower overseas.

The Dow is poised to retreat after padding the week's gains by 153.56 in Wednesday's trading. The Dow has climbed nearly 475 points since Friday's 281-point plunge.

Companies reporting earnings Thursday include HealthSouth Corp. (NYSE: HLS) and Dynegy Inc. (NYSE: DYN).

The Labor Department will give its weekly report on new unemployment claims at 8:30 a.m.

The Nikkei rose 1 percent to 17,240.99, pushed higher on news that Barneys New York has passed on a buyout bid from Japan's Fast Retailing. The FTSE 100 rose 1.33%.

In overseas currency markets, the dollar gained 0.3% on the euro, but slipped 0.7% against the yen.

Company news

AIG (NYSE: AIG) posted unexpectedly high income in its second-quarter report Wednesday, but cited cramping from weakness in the housing market.

News Corp, (NYSE: NWS) fresh off its successful bid for Dow Jones, reported higher profits over last year's fourth quarter.

Online search provider Infospace Inc. (NYSE: INSP) slipped overseas after reporting losses of 86 cents per share -- far worse than analysts' expectations of 12-cent losses.

HealthSouth Corporation (NYSE: HLS), the Alabama-based rehabilitation company, is close to completing a massive restructuring after years of tough times.

New management, three divestitures to be completed by the end of 2007 and a soon-to-be-more-friendly approach from Medicare and Medicaid, should allow this stock to perform nicely during the next three-to-five years.

HealthSouth was a boom-bust stock as former CEO Richard Scrushy built the diversified healthcare company into one of the larger and faster growing healthcare companies in the US during the 1990s. However, a number of financial irregularities came back to haunt Scrushy and his shareholders, leading to the stock tanking.

New management was brought in earlier this decade--well-respected execs from HCA--who first had to address the legal and accounting issues that plagued the company. Then last year the company announced it would begin selling non-core assets and become a focused rehab business.

The divestitures are for the most part completed and now the last part of the puzzle needs to be put in place. Medicare and Medicaid need to get the correct reimbursement rates so this very important industry can serve customers effectively and earn a return on investment. As boomers get older and stay more active, the rehab service that HealthSouth provides will become more and more important.

HealthSouth's stock ran up to $25 in anticipation of its three divestitures but has sold off to $20.50. Use this weakness to buy the stock, this could be a multi-bagger in the next few years.

MOST NOTEWORTHY: HealthSouth Corp (HLS) and CVS/Caremark Corp (CVS) were today's notable initiations:

• Cowen started HealthSouth (NYSE: HLS) an Neutral rating citing valuation.

• UBS resumed coverage of CVS/Caremark Corp (NASDAQ: CVS) with a Buy rating and $42 target, calling the company a "top pick."

OTHER INITIATIONS:

• Roth Capital initiated shares of Bakers Footwear Group, Inc (NASDAQ: BKRS) with a Hold rating and $11 target, taking a "wait and See approach" until sales can be maintained.

• JP Morgan initiated Ipsco Inc (NYSE: IPS) with an Overweight rating and USG Corp (NYSE: USG) with an Underweight rating.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required)